| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $21.38M | $4.10M | – | – | – |
| R&D | $6.62M | $661.18K | – | – | – |
| SG&A | $14.77M | $44.81K | $47.63K | $49.41K | $12.92K |
| Operating Income | -$21.38M | -$44.81K | -$47.63K | -$49.41K | -$12.92K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$61.00M | -$44.81K | -$47.63K | -$49.41K | -$12.92K |
| EPS (basic) | -2.4100 | -0.0100 | -0.0100 | -0.0100 | 0.0000 |
| EPS (diluted) | – | -0.5700 | -0.0100 | 0.0000 | -0.0100 |
| Shares (diluted) | – | $10.04M | $5.00M | $5.00M | $5.00M |